The world's leading automated proofreading software

8 Trends Shaping the Future of Drug Labeling

Published By:

Katarina Kresankova
4 minutes read
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Table of Contents

Future-Forward: 8 Key Trends Transforming Drug Labeling

1. Serialization and product authenticity

Serialization in pharmaceutical packaging and drug labeling is crucial to product safety, regulatory compliance, supply chain efficiency and the fight against counterfeit drugs. Unique information such as that stipulated in the US by the FDA Drug Supply Chain Security Act (DSCSA) laws [1] on serialization, and the Falsified Medicines Directive (Directive 2011/62/EU) [2] in the EU, goes hand-in-hand with technologies such as IIoT, AI and blockchain to enhance data transparency and real-time tracking in the supply chain.

2. Patient-Friendly Labeling

Pharma packaging and labeling is patient-friendly when it is clear, informative and easy for patients to understand. This promotes proper use and adherence. It is estimated that about 100,000 people die in the US alone due to not taking medication as prescribed. [3] However, patient-friendly labeling is also about how labeling is delivered – and here, e-labeling is the industry-changer. A European working group has produced an interesting paper on patient-friendly aspects in terms of content (see here). [4]

E-labeling is more than a trend, it is being mandated by regulatory bodies around the world. Apps allow patients to view digital labeling by scanning a QR code or using near-field communication and a smartphone (NFC; or in some cases a simple URL leading to a website). Information can be better exchanged and personalized to particular patient groups and in multiple language versions, overcoming the space limitations of physical labeling. This is the future everywhere – get ready for it. Start here, by reading our e-labeling book.

3. Enhanced packaging for usability and accessibility

Usability is about the ease of use, while accessibility is about is about having as few barriers as possible. It is inclusive and avoids wastefulness. Braille is voluntary in the US. The EU takes a different approach, making it mandatory. Accessible pharma packaging allows wider, more-independent patient reach, better-informed decision-making, and greater patient satisfaction. Electronic labeling offers many opportunities to make labeling more accessible as it is suitable for text-to-voice applications, or you can produce multilingual versions that would otherwise be impractical due to limited space on pharma labels.

4. Integration of digital technology in labeling

E-labeling is a breakthrough in how we share information. With the advent of Fast Healthcare Interoperability Resources (FHIR) format, information can now be shared more freely and reliably in apps and using QR codes or near-field communication (NFC) on smartphones to take the patient to a labeling platform. This opens up new opportunities to bundle patient labeling resources and information for patients (e.g. labels for all drugs a patient takes, and with a personal health record, along with other health records).

5. Compliance with Sustainability and Environmental Standards

The important discussion around drug residues and chemical production tends to overshadow sustainability and environmental standards in labeling itself. Electronic labeling has the potential to vastly reduce the amount of physical paper labeling required, and that is a boon for the environment. More information can also be provided on environmental aspects (e.g. on the proper disposal of medications).

Other aspects to consider are compliance with the European Union’s Green Deal [5] and the REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) requirements [6], as well as international ISO standards [7] on environmental management systems. Eco-friendly labeling and packaging (e.g. biodegradability, safe disposal instructions) is on the rise.

6. International Harmonization of Labeling Standards

Today’s trend is toward harmonization. European integration has been a key force in harmonization, but the development of other free-trade zones such as Mercosur in Latin America, the North American Free Trade Agreement (NAFTA), and the African Continental Free Trade Area (AfCFTA) are also drivers. In the case of Africa, harmonizing highly fragmented markets offers opportunities for greater local production and intra-Africa trade in medicines. This reduces import dependence. This World Economic Forum report provides interesting reading (see page 14 for pharmaceuticals) on harmonization in Africa. [8] Furthermore, within a World Health Organization framework, the African Medicines Regulatory Harmonization Initiative (AMRHI) is promoting coordination in technical, legislative, and procedural areas. [9] Since 1990, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has actively worked to establish technical standards.

7. Greater post-market surveillance and more-frequent labeling updates

Post-marketing surveillance is a cornerstone of drug regulation as not all possible side-effects of a product can be anticipated prior to authorization. Companies must continuously monitor real-world signals and gather real-world data. A risk management strategy must be in place in order to implement a labeling update on safety and efficacy as quickly as possible. Furthermore, e-labeling means faster updates, but also managing higher volumes of information.

8. New technologies, regulatory change and training

Flowing on from earlier points, FHIR is changing submission formats, e-labeling is increasing product transparency through the availability of more information, patient-centric healthcare is on the rise, and we can expect AI to play a greater role (find out more here in the area of promotional review) [10]. Regulatory change will accompany the technological changes, and also drive them. This requires new skills among professionals in the industry.

How TVT Tackles Drug Labeling Challenges


As pharmaceutical labeling evolves, challenges such as ensuring the accuracy of serialization, managing dual physical and electronic labeling, verifying accessible packaging like Braille, and keeping up with international harmonization and frequent updates continue to pose significant hurdles. Additionally, sustainability standards and the integration of digital technologies require careful navigation to maintain compliance and operational efficiency.


TVT offers an all-in-one solution to address these challenges. By automating proofreading and verification processes, TVT ensures error-free labeling, boosts compliance, and increases productivity. From verifying barcodes and Braille to handling dual labeling formats and integrating with digital platforms, TVT provides the tools necessary to stay ahead of regulatory demands. With TVT, companies can achieve labeling accuracy, reduce recall risks, and maintain confidence in a rapidly changing landscape.

Read more about trends shaping pharma and the medical device industry in The Road Ahead: Exploring Regulatory Trends Shaping Med Device and Pharma in 2025.

1. https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa2. https://health.ec.europa.eu/medicinal-products/falsified-medicines_en
3. https://news.uga.edu/patient-friendly-prescription-labels-boost-medication-adherence/
4. https://aesgp.eu/content/uploads/2024/03/AESGP-EFPIA-MfE_PP_Patient-information-on-medicinal-product-_2024.pdf
5. https://www.consilium.europa.eu/en/policies/green-deal/
6. https://echa.europa.eu/regulations/reach/understanding-reach
7. https://www.iso.org/standard/60857.html
8. https://www3.weforum.org/docs/WEF_Friends_of_the_Africa_Continental_Free_Trade_Area_2023.pdf
9. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/regulatory-convergence-networks/harmonization
10. https://www.schlafenderhase.com/shblog/regulatory-tools-revolutionizing-promo-review

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Share this article

Katarina Kresankova profile picture

Katarina Kresankova

Senior Account Executive, Schlafender Hase

Katarina has been a part of the sales team at Schlafender Hase, where she can combine her knowledge in sales with understanding of the importance of text accuracy backed up by her academic background.

Learn More

Subscribe to our blog

Future-Forward: 8 Key Trends Transforming Drug Labeling

1. Serialization and product authenticity

Serialization in pharmaceutical packaging and drug labeling is crucial to product safety, regulatory compliance, supply chain efficiency and the fight against counterfeit drugs. Unique information such as that stipulated in the US by the FDA Drug Supply Chain Security Act (DSCSA) laws [1] on serialization, and the Falsified Medicines Directive (Directive 2011/62/EU) [2] in the EU, goes hand-in-hand with technologies such as IIoT, AI and blockchain to enhance data transparency and real-time tracking in the supply chain.

2. Patient-Friendly Labeling

Pharma packaging and labeling is patient-friendly when it is clear, informative and easy for patients to understand. This promotes proper use and adherence. It is estimated that about 100,000 people die in the US alone due to not taking medication as prescribed. [3] However, patient-friendly labeling is also about how labeling is delivered – and here, e-labeling is the industry-changer. A European working group has produced an interesting paper on patient-friendly aspects in terms of content (see here). [4]

E-labeling is more than a trend, it is being mandated by regulatory bodies around the world. Apps allow patients to view digital labeling by scanning a QR code or using near-field communication and a smartphone (NFC; or in some cases a simple URL leading to a website). Information can be better exchanged and personalized to particular patient groups and in multiple language versions, overcoming the space limitations of physical labeling. This is the future everywhere – get ready for it. Start here, by reading our e-labeling book.

3. Enhanced packaging for usability and accessibility

Usability is about the ease of use, while accessibility is about is about having as few barriers as possible. It is inclusive and avoids wastefulness. Braille is voluntary in the US. The EU takes a different approach, making it mandatory. Accessible pharma packaging allows wider, more-independent patient reach, better-informed decision-making, and greater patient satisfaction. Electronic labeling offers many opportunities to make labeling more accessible as it is suitable for text-to-voice applications, or you can produce multilingual versions that would otherwise be impractical due to limited space on pharma labels.

4. Integration of digital technology in labeling

E-labeling is a breakthrough in how we share information. With the advent of Fast Healthcare Interoperability Resources (FHIR) format, information can now be shared more freely and reliably in apps and using QR codes or near-field communication (NFC) on smartphones to take the patient to a labeling platform. This opens up new opportunities to bundle patient labeling resources and information for patients (e.g. labels for all drugs a patient takes, and with a personal health record, along with other health records).

5. Compliance with Sustainability and Environmental Standards

The important discussion around drug residues and chemical production tends to overshadow sustainability and environmental standards in labeling itself. Electronic labeling has the potential to vastly reduce the amount of physical paper labeling required, and that is a boon for the environment. More information can also be provided on environmental aspects (e.g. on the proper disposal of medications).

Other aspects to consider are compliance with the European Union’s Green Deal [5] and the REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) requirements [6], as well as international ISO standards [7] on environmental management systems. Eco-friendly labeling and packaging (e.g. biodegradability, safe disposal instructions) is on the rise.

6. International Harmonization of Labeling Standards

Today’s trend is toward harmonization. European integration has been a key force in harmonization, but the development of other free-trade zones such as Mercosur in Latin America, the North American Free Trade Agreement (NAFTA), and the African Continental Free Trade Area (AfCFTA) are also drivers. In the case of Africa, harmonizing highly fragmented markets offers opportunities for greater local production and intra-Africa trade in medicines. This reduces import dependence. This World Economic Forum report provides interesting reading (see page 14 for pharmaceuticals) on harmonization in Africa. [8] Furthermore, within a World Health Organization framework, the African Medicines Regulatory Harmonization Initiative (AMRHI) is promoting coordination in technical, legislative, and procedural areas. [9] Since 1990, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has actively worked to establish technical standards.

7. Greater post-market surveillance and more-frequent labeling updates

Post-marketing surveillance is a cornerstone of drug regulation as not all possible side-effects of a product can be anticipated prior to authorization. Companies must continuously monitor real-world signals and gather real-world data. A risk management strategy must be in place in order to implement a labeling update on safety and efficacy as quickly as possible. Furthermore, e-labeling means faster updates, but also managing higher volumes of information.

8. New technologies, regulatory change and training

Flowing on from earlier points, FHIR is changing submission formats, e-labeling is increasing product transparency through the availability of more information, patient-centric healthcare is on the rise, and we can expect AI to play a greater role (find out more here in the area of promotional review) [10]. Regulatory change will accompany the technological changes, and also drive them. This requires new skills among professionals in the industry.

How TVT Tackles Drug Labeling Challenges


As pharmaceutical labeling evolves, challenges such as ensuring the accuracy of serialization, managing dual physical and electronic labeling, verifying accessible packaging like Braille, and keeping up with international harmonization and frequent updates continue to pose significant hurdles. Additionally, sustainability standards and the integration of digital technologies require careful navigation to maintain compliance and operational efficiency.


TVT offers an all-in-one solution to address these challenges. By automating proofreading and verification processes, TVT ensures error-free labeling, boosts compliance, and increases productivity. From verifying barcodes and Braille to handling dual labeling formats and integrating with digital platforms, TVT provides the tools necessary to stay ahead of regulatory demands. With TVT, companies can achieve labeling accuracy, reduce recall risks, and maintain confidence in a rapidly changing landscape.

Read more about trends shaping pharma and the medical device industry in The Road Ahead: Exploring Regulatory Trends Shaping Med Device and Pharma in 2025.

1. https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa2. https://health.ec.europa.eu/medicinal-products/falsified-medicines_en
3. https://news.uga.edu/patient-friendly-prescription-labels-boost-medication-adherence/
4. https://aesgp.eu/content/uploads/2024/03/AESGP-EFPIA-MfE_PP_Patient-information-on-medicinal-product-_2024.pdf
5. https://www.consilium.europa.eu/en/policies/green-deal/
6. https://echa.europa.eu/regulations/reach/understanding-reach
7. https://www.iso.org/standard/60857.html
8. https://www3.weforum.org/docs/WEF_Friends_of_the_Africa_Continental_Free_Trade_Area_2023.pdf
9. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/regulatory-convergence-networks/harmonization
10. https://www.schlafenderhase.com/shblog/regulatory-tools-revolutionizing-promo-review

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Subscribe to our blog

Related Blogs

February 5, 2025

Schlafender Hase Team

Med Tech in a Globalized World: Overcoming Regulatory Compliance Challenges for International Success

Despite stakeholders’ efforts to harmonize the medical device industry across regulatory jurisdictions, manufacturers face significant challenges in achieving global regulatory compliance. Gradually, however, we are seeing greater recognition globally of quality standards. In regions beyond Europe and North America, harmonization initiatives are well underway.

7 minutes read

Med Tech in a Globalized World: Overcoming Regulatory Compliance Challenges for International Success

Despite stakeholders’ efforts to harmonize the medical device industry across regulatory jurisdictions, manufacturers face significant challenges in achieving global regulatory compliance. Gradually, however, we are seeing greater recognition globally of quality standards. In regions beyond Europe and North America, harmonization initiatives are well underway.

February 3, 2025

Schlafender Hase Team

The Future of Labels: Embracing Digital Technology for Enhanced Efficiency

Think back to the early days of labeling – when medicines were sold by salespeople at events resembling circuses more than genuine health events. Consumers often had little to no knowledge of what was inside the medication bottle. In fact, the first US regulation on labeling, introduced in 1906, merely required that any listed contents were truthful.

5 minutes read

The Future of Labels: Embracing Digital Technology for Enhanced Efficiency

Think back to the early days of labeling – when medicines were sold by salespeople at events resembling circuses more than genuine health events. Consumers often had little to no knowledge of what was inside the medication bottle. In fact, the first US regulation on labeling, introduced in 1906, merely required that any listed contents were truthful.

January 13, 2025

Schlafender Hase Team

E-labeling: The Road to Efficient Pharmaceutical Labeling and Packaging

Practical next steps for pharmaceutical manufacturers & distributors as regulators demand the digital delivery of customer-facing product information in place of paper inserts.

< 1 minute read

E-labeling: The Road to Efficient Pharmaceutical Labeling and Packaging

Practical next steps for pharmaceutical manufacturers & distributors as regulators demand the digital delivery of customer-facing product information in place of paper inserts.